These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38391530)

  • 21. Omadacycline and
    Garey KW; Rose W; Gunter K; Serio AW; Wilcox MH
    Ann Pharmacother; 2023 Feb; 57(2):184-192. PubMed ID: 35656828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
    Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
    mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Antibiotic Prophylaxis in Urology and High Incidence of
    Jachowicz E; Wałaszek M; Sulimka G; Maciejczak A; Zieńczuk W; Kołodziej D; Karaś J; Pobiega M; Wojkowska-Mach J
    Microorganisms; 2020 May; 8(6):. PubMed ID: 32481654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duration from start of antibiotic exposure to onset of
    Karp J; Edman-Wallér J; Jacobsson G
    Infect Dis (Lond); 2024 Jul; ():1-8. PubMed ID: 39023136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-Discharge
    Jachowicz E; Pac A; Różańska A; Gryglewska B; Wojkowska-Mach J
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328843
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterizing Risk Factors for Clostridioides difficile Infection among Hospitalized Patients with Community-Acquired Pneumonia.
    Rhodes NJ; Jozefczyk CC; Moore WJ; Yarnold PR; Harkabuz K; Maxwell R; Sutton SH; Silkaitis C; Qi C; Wunderink RG; Zembower TR
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0041721. PubMed ID: 33875439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Different Antibiotics and the Risk for Community-Associated
    Miller AC; Arakkal AT; Sewell DK; Segre AM; Tholany J; Polgreen PM;
    Open Forum Infect Dis; 2023 Aug; 10(8):ofad413. PubMed ID: 37622034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
    Webb BJ; Subramanian A; Lopansri B; Goodman B; Jones PB; Ferraro J; Stenehjem E; Brown SM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964789
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of Antibiotic Exposure Intensity on the Risk of Clostridioides difficile Infection.
    Ray MJ; Strnad LC; Tucker KJ; Furuno JP; Lofgren ET; McCracken CM; Park H; Gerber JS; McGregor JC
    Clin Infect Dis; 2024 May; ():. PubMed ID: 38743579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Costs Associated with the Treatment of Clostridioides Difficile Infections.
    Sierocka A; Kiersnowska Z; Lemiech-Mirowska E; Marczak M
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34300098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healthcare facility-onset, healthcare facility-associated
    Evans CT; Fitzpatrick M; Ramanathan S; Kralovic SM; Burns SP; Goldstein B; Smith B; Gerding DN; Johnson S
    J Spinal Cord Med; 2020 Sep; 43(5):642-652. PubMed ID: 31663843
    [No Abstract]   [Full Text] [Related]  

  • 32. Association of Household Exposure to Primary Clostridioides difficile Infection With Secondary Infection in Family Members.
    Miller AC; Segre AM; Pemmaraju SV; Sewell DK; Polgreen PM
    JAMA Netw Open; 2020 Jun; 3(6):e208925. PubMed ID: 32589232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of Clostridioides difficile infection (CDI) related to antibiotic prescribing by GP surgeries in Wales.
    Tydeman F; Craine N; Kavanagh K; Adams H; Reynolds R; McClure V; Hughes H; Hickman M; Robertson C
    J Antimicrob Chemother; 2021 Aug; 76(9):2437-2445. PubMed ID: 34151964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The microbial diversity following antibiotic treatment of Clostridioides difficile infection.
    Binyamin D; Nitzan O; Azrad M; Hamo Z; Koren O; Peretz A
    BMC Gastroenterol; 2021 Apr; 21(1):166. PubMed ID: 33849457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The
    Wickramage I; Peng Z; Chakraborty S; Harmanus C; Kuijper EJ; Alrabaa S; Smits WK; Sun X
    Microbiol Spectr; 2023 Jun; 11(3):e0377722. PubMed ID: 37125917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut microbiota in burned patients with Clostridioides difficile infection.
    Shoaei P; Shojaei H; Siadat SD; Moshiri A; Vakili B; Yadegari S; Ataei B; Khorvash F
    Burns; 2022 Aug; 48(5):1120-1129. PubMed ID: 34924229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Community Factors with Hospital-onset
    Zacharioudakis IM; Zervou FN; Shehadeh F; Mylona EK; Mylonakis E
    EClinicalMedicine; 2019 Feb; 8():12-19. PubMed ID: 31193719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hospital acquired Clostridioides difficile infection and risk factors for severity in a university hospital: A prospective study.
    Bilgin H; Sayın E; Gürün HP; Tükenmez-Tigen E; Ülger Toprak N; Korten V
    Am J Infect Control; 2020 Dec; 48(12):1426-1430. PubMed ID: 32522607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective, observational study of fidaxomicin use for
    Guery B; Berger P; Gauzit R; Gourdon M; Barbut F; ; Dafne Study Group ; Bémer P; Bessède E; Camou F; Cattoir V; Couzigou C; Descamps D; Dinh A; Laurans C; Lavigne JP; Lechiche C; Leflon-Guibout V; Le Monnier A; Levast M; Mootien JY; N'Guyen Y; Piroth L; Prazuck T; Rogeaux O; Roux AL; Vachée A; Vernet Garnier V; Wallet F
    J Int Med Res; 2021 Jun; 49(6):3000605211021278. PubMed ID: 34162264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
    Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
    Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.